Angarmurun Dayan

Angarmurun Dayan

Auto-generated profile, based on publicly available information

Angarmurun Dayan

Mongolian Natl Univ Med Sci, Sch Publ Hlth, Zorigs St, Ulaanbaatar 12100, Mongolia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2022 in Journal of Preventive Medicine and Public Health
Verified
Journal Article
Open access
PDF file
DDDavaalkham Dambadarjaa
Davaalkham Dambadarjaa
YMYerkyebulan Mukhtar
Yerkyebulan Mukhtar
ETEnkh-Oyun Tsogzolbaatar
Enkh-Oyun Tsogzolbaatar
SKSer-Od Khuyag
Ser-Od Khuyag
ADAngarmurun Dayan
Angarmurun Dayan
HOHiroaki Okamoto
Hiroaki Okamoto
Objectives: Infections with hepatitis B, C, and D virus (HBV, HCV, and HDV) are a major public health problem and lead to serious complications such as cirrhosis and hepatocellular carcinoma. We aimed to determine the seroprevalence of hepatitis B surface antigen (HBsAg), anti-HCV, anti-HDV immunoglobulin G, alpha-fetoprotein (AFP), and dual and triple hepatitis virus infections in Mongolia.Methods: A total of 2313 participants from urban and rural regions were randomly recruited for this cross-sectional study. A questionnaire was used to identify the risk factors for hepatitis virus infections, and the seromarkers were measured using immunoassay kits.Results: Among all participants, the prevalence of HBV, HCV, and HDV was 15.6%, 36.6%, and 14.3%, respectively. The infection rates were significantly higher in females and participants with a lower education level, rural residence, older age, and a history of blood transfusion. HBV and HCV co-infection was found in 120 (5.2%) participants and HBV, HCV, and HDV triple infection was detected in 67 (2.9%) participants. The prevalence of elevated AFP was 2.7%, 5.5%, and 2.6% higher in participants who were seropositive for HBsAg (p=0.01), anti-HCV (p<0.001), and anti-HDV (p=0.022), respectively. Elevated AFP was more prevalent in participants co-infected with HBV and HCV (5.8%, p=0.023), HBV and HDV (6.0%, p<0.001), and triple-infected with HBV, HCV, and HDV (7.5%) than in uninfected individuals.Conclusions: Nearly half (49.8%) of the study population aged ≥40 years were infected with HBV, HCV, or HDV, and 22.4% had dual or triple infections.